Navigation Links
Golden West Biologicals, Inc. and Sunfco, Ltd. Expand Sales of Vitamin D Free Human Serum in Japan

TEMECULA, Calif. and TOKYO, July 26, 2013 /PRNewswire-iReach/ -- Golden West Biologicals, Inc. (GWB), a leading provider and manufacturer of diagnostic products and Sunfco, Ltd., a leading provider of raw material ingredients for food products, medicinal products, biotech products, health food products and other products in the fine chemicals field, today announced the rapid growth in sales of GWB's Mass Spect Gold® line of human serum in Japan.


"Our partnership with Sunfco has created a strong distribution channel for our Mass Spec Gold products," said Tammy Guenthner, Manufacturing Manager at GWB.  "Sunfco's deep knowledge of the diagnostics market in Japan has enabled us to dramatically increase our sales over last year."

GWB supplies Sunfco with a broad range of products used in the diagnostics industry.  After the United States and European Union, Japan is the World's 3rd largest In-Vitro Diagnostics (IVD) market.  And due to demographic shifts in Japan, the industry is expected to show further growth.

About Golden West Biologicals, Inc.

Golden West Biologicals, Inc. (GWB) is a privately held company headquartered in Temecula, California.  The company was formed in 1989 to directly address the need for cost effective and technically superior biological raw materials for the development of immunoassays and LC-MS applications.  GWB provides manufacturers and laboratories with over 80 human and animal biological products including Vitamin D free human serum, human serum for ultra-sensitive testing, human serum albumin/gamma globulin, and rabbit gamma globulin.  Additional information, including the complete line of products, can be found at the company website

About Sunfco Ltd.

Sunfco Ltd. was established by the capital investments of Morinaga Milk Industry Co., Ltd., Taiyo Kagaku Co., Ltd., and Kaei Trading Co., Ltd. as "Sun Friend Chemical Ltd." on March 1, 1979.  Since its founding, the company has sought to supply and develop raw material ingredients and products for the benefit of its customers through a policy of honesty and integrity.

In September 1989, the company changed its name to "Sunfco Ltd." due to a healthy expansion of its business owing to the steady patronage of its valued customers.

Based on its ability to rapidly respond to the dramatic changes of our time, the company offers unique raw material ingredients for food products, medicinal products, biotech products, health food products and other products in the fine chemicals field as well as knowledge products (intermediary services for entrusting processing services) in advancing globalization and specialization.  Additional information, including the complete line of products, can be found at the company website

For more information:
Golden West Biologicals, Inc.
Ward Komers
Phone: 888-690-0963

Sunfco Ltd.
Shozo Shimada
1-8-3 Kaji-cho
Tokyo 101-0044 (Kanda91 Building 8F)

Media Contact: Brian Golie, Golden West Biologicals, Inc., 951-699-0957,

News distributed by PR Newswire iReach:

SOURCE Golden West Biologicals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Golden West Biologicals, Inc. Exhibiting at AACC Clinical Lab Expo 2013
2. China Cord Blood Corporation and Golden Meditech Holdings Limited Enter into Convertible Note Financing to Further Expand Cord Blood Banking Services
3. Golden potential for gold thin films
4. CellerateRX® Added to List of Preferred Products for Golden Living Healthcare Network
5. Tissue Culture Biologicals, Inc. Hires James D. Titus to Lead New Expansion and Branding Development Effort
6. PhoenixSongs Biologicals, Inc. Announces Enhanced Neural Lineage-specific Cell Culture Media Products Release
7. Life Technologies Expands CEERAM Food Safety Range to Global Market
8. Cardno Expands to Include a New Business Line Focused on Health Sciences
9. Elliott Broidy Expands Role in Los Angeles Civics with Support of Stem Cell Research Program
10. Rare collection that may hold key to oceans biggest mysteries looks to expand in new waterfront home
11. PharmSource CMO-CDMO Database Expands Coverage to Include Approved Pharmaceutical Products: Intelligence Resource for Analyzing Bio/Pharmaceutical Contract Manufacturing
Post Your Comments:
(Date:11/26/2015)... , England , November 26, 2015 /PRNewswire/ ... Medical, an innovative medical device company specializing in imaging technologies, ... from the European Commission as part of the Horizon 2020 ... company to carry out a large-scale clinical trial in breast ...      (Logo: , --> ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE ... has adopted a stockholder rights plan (Rights Plan) in ... operating loss carryforwards (NOLs) under Section 382 of the ... --> PharmAthene,s use of its NOLs could ... change" as defined in Section 382 of the Code. ...
(Date:11/25/2015)... -- Studies reveal the differences in species ... the way for more effective treatment for one of the ... --> --> Gum disease ... cats, yet relatively little was understood about the bacteria associated ... conducted by researchers from the WALTHAM Centre for Pet Nutrition ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
Breaking Biology Technology:
(Date:11/18/2015)... , November 18, 2015 ... has published a new market report titled  Gesture Recognition ... and Forecast, 2015 - 2021. According to the report, the global ... and is anticipated to reach US$29.1 bn by 2021, ... North America dominated the ...
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
Breaking Biology News(10 mins):